Colchicine and risk of COVID-19-associated hospitalization.

In a recent population-based study conducted by Dr. Sáenz-Aldea and colleagues, colchicine was reported to have neutral influence to the risk of COVID-19 associated hospitalization and the susceptibility to COVID-19 viruses 1 . We studied the study with great interest. Due to the study setting based on electronic medical records from citizens, covariates were rigorously considered and in turn making the researching results of the aforementioned study was convincible This article is protected by copyright. All rights reserved.